Safety of Infliximab During Perioperative Period in Crohn Disease Patients

REN Hua-jian,REN Jian-an
DOI: https://doi.org/10.3760/cma.j.issn.1673-4203.2012.10.019
2012-01-01
Abstract:With the appearance of new biological agents represented by infliximab,the medical therapy of crohns' disease has made breakthrough of progress.However,the controversial still remains about the use of infliximab during perioperative period in Crohn's disease patients.The aim of this article is to explore the influence of infliximab on postoperative complications in Crohn's disease patients.
What problem does this paper attempt to address?